Inventor · disambiguated record
Douglas T. Fearon
Also filed as: FEARON DOUGLAS · FEARON DOUGLAS T
9 granted patents·4 pending applications·467 citations·filing 1989–2018
92Inventor score
Top patents by PatentIndex Score
13 records- 0192US5212071ANucleic acids encoding a human C3b/C4b receptor (CR1)UNIV JOHNS HOPKINS·Filed 1989·Granted May 18, 1993·100 cites·64 claims
- 0290US5472939AMethod of treating complement mediated disordersUNIV JOHNS HOPKINS·Filed 1993·Granted Dec 5, 1995·70 cites·37 claims
- 0389US5981481AHuman C3b/C4b receptor (CR1)UNIV JOHNS HOPKINS·Filed 1995·Granted Nov 9, 1999·80 cites·42 claims
- 0486US5856297AHuman C3b/C4b receptor (CR1)UNIV JOHNS HOPKINS·Filed 1995·Granted Jan 5, 1999·58 cites·14 claims
- 0586US5256642ACompositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereofUNIV JOHNS HOPKINS·Filed 1990·Granted Oct 26, 1993·49 cites·13 claims
- 0680US6458360B1Soluble complement regulatory moleculesUNIV JOHNS HOPKINS·Filed 1991·Granted Oct 1, 2002·58 cites·29 claims
- 0780US6316604B1Human C3b/C4b receptor (CR1)AVANT IMMUNOTHERAPEUTICS INC·Filed 1995·Granted Nov 13, 2001·46 cites·14 claims
- 0867US6891027B2Modulating the immune responseUNIV CAMBRIDGE TECH·Filed 2001·Granted May 10, 2005·1 cites·6 claims
- 0963US2018228894A1Inhibition of cxcr4 signaling in cancer immunotherapyCAMBRIDGE ENTPR LTD·Filed 2018·Application pending·0 cites
- 1057US2015352208A1Inhibition of cxcr4 signaling in cancer immunotherapyCAMBRIDGE ENTPR LTD·Filed 2015·Application pending·0 cites
- 1156US2015216843A1Inhibition of cxcr4 signaling in cancer immunotherapyCAMBRIDGE ENTPR LTD·Filed 2015·Application pending·0 cites
- 1239US6238670B1Compositions and methods employing a ligand for CD21 or CD19 for modulating the immune response to an antigenUNIV CAMBRIDGE TECH·Filed 1995·Granted May 29, 2001·5 cites·38 claims
- 1338US2002168383A1Modifications of antigens by the introduction of aldehyde groups and their use in enhancing the immune responseUNIV CAMBRIDGE TECH·Filed 2001·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →